Cardiac and Renal Effects of Growth Hormone in Volume Overload–Induced Heart Failure
- 1 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 39 (1) , 57-62
- https://doi.org/10.1161/hy0102.098323
Abstract
Growth hormone (GH) application is a new strategy in the treatment of heart failure. However, clinical and experimental investigations have shown contradictory effects of GH on cardiac performance. We tested the hypothesis that GH could improve cardiac and renal function in volume overload–induced heart failure. The effect of 4 weeks of GH treatment (2 mg/kg daily) was investigated in Wistar rats with aortocaval shunt. GH application did not influence left ventricular contractility and end-diastolic pressure in rats with aortocaval shunt. In contrast, GH treatment normalized impaired diuresis (vehicle 10.8±0.6 mL/d, GH 15.8±0.7 mL/d; P P P P N G -nitro- l -arginine methyl ester. GH treatment did not influence cardiac function in rats with aortocaval shunts. However, GH improved renal function by increasing diuresis and sodium excretion. The responsible mechanism might be the enhanced activity of the renal NO system.Keywords
This publication has 13 references indexed in Scilit:
- Effects of Sodium Nitroprusside on Renal Functions and NO-cGMP Production in Anesthetized DogsJournal of Cardiovascular Pharmacology, 1999
- Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activationJournal of the American College of Cardiology, 1998
- Regulatory mechanisms of growth hormone secretion are sexually dimorphic.Journal of Clinical Investigation, 1998
- Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathyThe Lancet, 1998
- Haemodynamic effects of intravenous growth hormone in congestive heart failureThe Lancet, 1997
- Improved Methods to Measure End Products of Nitric Oxide in Biological Fluids: Nitrite, Nitrate, andS-NitrosothiolsNitric Oxide, 1997
- Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.Journal of Clinical Investigation, 1996
- A Preliminary Study of Growth Hormone in the Treatment of Dilated CardiomyopathyNew England Journal of Medicine, 1996
- Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.Proceedings of the National Academy of Sciences, 1995
- The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin systemMetabolism, 1990